Por: Ars Technica Science November 14, 2022
John became Ars Technica's science editor in 2007 after spending 15 years doing biology research at places like Berkeley and Cornell. Email // Twitter... + full article
Time USA Health November 11, 2022
Researchers have made an important step forward toward a long-desired goal: using the gene-editing technology to treat cancer. In a , scientists recruited 16 people who had already received standard treatment for their cancer (which included colon, head and neck, lung, skin, and... + más
Starting a Revolution Isn’t Enough | The Atlantic
Personalized cancer treatment edges closer with CRISPR trial success | Newsweek
New York Post USA Life November 11, 2022
Those living with cancer may soon be eligible for the most bespoke treatment to date. New research has the potential to revolutionize the battle against cancer by “editing” patients’ own cells to fight their unique disease profile. As part of a clinical trial, published in... + más
Boston startup Ascidian Therapeutics charts vision for therapies that ‘rewrite RNA’ | The Boston Globe
Newsweek USA Health November 10, 2022
A new cancer treatment that trains the patient's own immune system to target tumor cells has been developed and successfully trialed in human cancer patients.The therapy uses the CRISPR-Cas9 system for genetic engineering and paves the way for future advances in... + más
‘Personalized’ cell ‘editing’ could revolutionize cancer treatment: study | New York Post
The Boston Globe USA Business October 12, 2022
Competition is heating up among biotech startups building technologies that improve or expand upon what gene editing can do. While most of these firms are devising therapies that permanently modify DNA to treat, and potentially cure, genetic diseases, a growing number think that... + más
Tech insiders have a lot to say about the local startup scene. Most of it is good. | The Boston Globe
See the presentations that hot healthcare startups used to raise millions from top VCs | Business Insider
Ars Technica USA Science October 06, 2022
Navigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Oct 6, 2022 12:00 pm UTC / A 3D illustration of the HIV virus. Share this story In July, an HIV-positive man became the first... + más
HIV-positive people who have monkeypox are hospitalized more often, CDC study says | CNBC
The New York Times USA Science September 29, 2022
In a surprise discovery, researchers found that cells from some types of cancers escaped destruction by the immune system by hiding inside other cancer cells.The finding, they suggested in published this month in the journal eLife, may explain why some cancers can be resistant... + más
Cancer in people under 50 is rising around the world. Why? | WGN-TV
What you need to know about 'original antigenic sin' with fall COVID boosters around the corner | ABC News
The Atlantic USA Science September 24, 2022
CRISPR is changing the world—but it can do more.Erik Carter / The AtlanticSeptember 12, 2022Two years ago, I was working on my laptop in an airport lounge in Newark, New Jersey, when I glanced up and saw a couple walking with their two boys. The younger boy slowly made his way... + más
Teenagers on Revolution roster have provided a spark that bodes well for the future | The Boston Globe
‘I Think the Women Are Winning’ | The Atlantic
About iurex | Privacy Policy | Disclaimer |